Berkeley, California
United States
28
2023-03-23
The entities that hold a legal rights for patent applications filed by inventor BOYD BROOKS M.:
BROOKS M. BOYD from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:
CHANGING COGNITIVE FUNCTION WITH FENFLURAMINE
#2 | 2023-03-09NORFENFLURAMINE TO TREAT DRAVET SYNDROME
#3 | 2022-11-24COMPOSITIONS AND METHODS FOR TREATING SEIZURE DISORDERS
#4 | 2022-09-15Metabolism resistant fenfluramine analogs and methods of using the same
#5 | 2020-10-22Metabolism resistant fenfluramine analogs and methods of using the same
#6 | 2020-10-01CHANGING COGNITIVE FUNCTION WITH FENFLURAMINE
#7 | 2020-09-24COMPOSITIONS AND METHODS FOR TREATING SEIZURE DISORDERS
#8 | 2020-09-03METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME
#9 | 2020-08-20Ketogenic diet compatible fenfluramine formulation
#10 | 2019-08-15METHOD OF REDUCTION IN CONVULSIVE SEIZURE FREQUENCY
#11 | 2019-05-02METHOD OF REDUCTION IN CONVULSIVE SEIZURE FREQUENCY
#12 | 2019-03-28CONGNITIVE FUNCTION WITH FENFLURAMINE
#13 | 2019-03-28Ketogenic diet compatible fenfluramine formulation
#14 | 2019-03-28METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME
#15 | 2019-03-28METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME
#16 | 2019-03-28METHOD OF REDUCTION MEDICATION IN TREATING DRAVET SYNDROME
#17 | 2019-03-28METHOD OF REDUCING SEIZURE TYPE EXPERIENCED BY A DRAVET PATIENT
#18 | 2019-03-28METHOD OF INCREASING TIME BETWEEN CONVULSIVE SEIZURES
#19 | 2019-01-03Metabolism resistant fenfluramine analogs and methods of using the same
#20 | 2018-04-05COMPOSITIONS AND METHODS FOR TREATING SEIZURE DISORDERS
#21 | 2017-06-22METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME
#22 | 2017-03-09PISTON CLOSURES FOR DRUG DELIVERY CAPSULES
#23 | 2016-05-12Needle-free injectors and design parameters thereof that optimize injection performance
#24 | 2014-08-07Needle-free injectors and design parameters thereof that optimize injection performance
#25 | 2012-11-22Viscous formulations and their use in needle-free injection
#26 | 2011-08-11Viscous formulations and their use in needle-free injection
#27 | 2008-09-04Viscous formulations and their use in needle-free injection
#28 | 2005-12-01Aerosol drug delivery system employing formulation pre-heating
864800 ⎘